Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 14, 2025 • 6:31 PM ET

Date/Time Source News Release
03/13/2025 08:30 AM EDT GlobeNewswire Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
02/25/2025 09:20 AM EST GlobeNewswire Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials
02/11/2025 09:00 AM EST GlobeNewswire Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
02/04/2025 09:00 AM EST GlobeNewswire Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
01/30/2025 08:30 AM EST GlobeNewswire Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
01/16/2025 08:30 AM EST GlobeNewswire Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
12/03/2024 09:00 AM EST GlobeNewswire Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed
11/26/2024 08:30 AM EST GlobeNewswire Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment
11/12/2024 08:30 AM EST GlobeNewswire Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
11/07/2024 08:30 AM EST GlobeNewswire Femasys to Exhibit at the Annual AAGL 2024 Global Conference
Page

Additional News

As of March 14, 2025 • 6:31 PM ET

Date/Time Source News Release
01/30/2025 09:11 AM EST SeekingAlpha Femasys announces notices of intention to grant for two new European patent applications
01/16/2025 09:58 AM EST SeekingAlpha Femasys gets notice of allowance for new U.S. patent application covering use of Femaseed
11/19/2024 04:39 AM EST US Earnings Reports Expected earnings - Femasys Inc.
11/12/2024 09:59 AM EST SeekingAlpha Femasys GAAP EPS of -$0.24, revenue of $554.91M
11/12/2024 09:45 AM EST Zacks Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates
11/07/2024 07:05 AM EST Zacks Zealand Pharma A/S (ZLDPF) Reports Q3 Loss, Lags Revenue Estimates
11/06/2024 05:15 PM EST Zacks Arcutis Biotherapeutics, Inc. (ARQT) Reports Q3 Loss, Tops Revenue Estimates
09/11/2024 08:47 AM EDT SeekingAlpha Femasys secures partnerships for commercialization of Femaseed and FemVue
09/10/2024 10:41 AM EDT Zacks Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device
09/07/2024 05:39 AM EDT US Earnings Reports Expected earnings - Femasys Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.